Melasma: A comprehensive update Part II

被引:156
作者
Sheth, Vaneeta M. [2 ]
Pandya, Amit G. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA
关键词
chemical peels; chloasma; hydroquinone; laser therapy; melasma; pigmentation; GLYCOLIC ACID PEELS; SWITCHED ALEXANDRITE LASER; BROAD-SPECTRUM SUNSCREEN; INTENSE PULSED-LIGHT; RETINOIC ACID; DOUBLE-BLIND; 4-PERCENT HYDROQUINONE; REFRACTORY MELASMA; AZELAIC ACID; LACTIC-ACID;
D O I
10.1016/j.jaad.2011.06.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment. (J Am Acad Dermatol 2011;65:699-714.)
引用
收藏
页码:699 / 714
页数:16
相关论文
共 89 条
[1]   Whitening effect of salicylic acid peels in Asian patients [J].
Ahn, HH ;
Kim, IH .
DERMATOLOGIC SURGERY, 2006, 32 (03) :372-375
[2]  
Alster T S., 2001, Dermatol Ther, V14, P46
[3]   Topical hydroquinone in the treatment of some hyperpigmentary disorders [J].
Amer, M ;
Metwalli, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (06) :449-450
[4]   Topical liquiritin improves melasma [J].
Amer, M ;
Metwalli, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (04) :299-301
[5]   Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma:: Split-face design [J].
Angsuwarangsee, S ;
Polnikorn, N .
DERMATOLOGIC SURGERY, 2003, 29 (01) :59-64
[6]  
[Anonymous], 2006, SKIN BLEACH DRUG PRO
[7]   THE TREATMENT OF MELASMA - 20-PERCENT AZELAIC ACID VERSUS 4-PERCENT HYDROQUINONE CREAM [J].
BALINA, LM ;
GRAUPE, K .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (12) :893-895
[8]   DeoxyArbutin:: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency [J].
Boissy, RE ;
Visscher, M ;
deLong, MA .
EXPERIMENTAL DERMATOLOGY, 2005, 14 (08) :601-608
[9]   Chemical and instrumental approaches to treat hyperpigmentation [J].
Briganti, S ;
Camera, E ;
Picardo, M .
PIGMENT CELL RESEARCH, 2003, 16 (02) :101-110
[10]  
Cestari Tania, 2007, J Drugs Dermatol, V6, P153